J. L. Hülsemann

719 total citations
31 papers, 539 citations indexed

About

J. L. Hülsemann is a scholar working on Rheumatology, Rehabilitation and General Health Professions. According to data from OpenAlex, J. L. Hülsemann has authored 31 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Rheumatology, 12 papers in Rehabilitation and 7 papers in General Health Professions. Recurrent topics in J. L. Hülsemann's work include Rheumatoid Arthritis Research and Therapies (18 papers), Musculoskeletal Disorders and Rehabilitation (12 papers) and Spondyloarthritis Studies and Treatments (10 papers). J. L. Hülsemann is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Musculoskeletal Disorders and Rehabilitation (12 papers) and Spondyloarthritis Studies and Treatments (10 papers). J. L. Hülsemann collaborates with scholars based in Germany, Switzerland and France. J. L. Hülsemann's co-authors include H. Zeidler, H Zeidler, M. C. Jendro, Annette D. Wagner, Jörg Ruof, N. Roeder, H.‐J. Lakomek, Gerold Stucki, Sonja Merkesdal and Elisabeth Märker‐Hermann and has published in prestigious journals such as Annals of the Rheumatic Diseases, Current Opinion in Rheumatology and BMC Medical Informatics and Decision Making.

In The Last Decade

J. L. Hülsemann

31 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. L. Hülsemann Germany 13 406 119 66 62 54 31 539
Jamal Al Saleh United Arab Emirates 10 200 0.5× 123 1.0× 129 2.0× 75 1.2× 90 1.7× 31 546
S. Oliver United Kingdom 6 404 1.0× 197 1.7× 30 0.5× 17 0.3× 122 2.3× 6 557
Charles Lambert United Kingdom 10 176 0.4× 93 0.8× 19 0.3× 15 0.2× 21 0.4× 13 298
Maria K. Söderlin Sweden 15 551 1.4× 179 1.5× 28 0.4× 8 0.1× 124 2.3× 26 689
Jenaro Graña Gil Spain 10 115 0.3× 84 0.7× 65 1.0× 13 0.2× 33 0.6× 29 394
Pil Højgaard Denmark 12 510 1.3× 227 1.9× 116 1.8× 17 0.3× 361 6.7× 33 721
N. Santana Mexico 6 186 0.5× 86 0.7× 29 0.4× 43 0.7× 47 0.9× 8 329
Ihab Ahmed Egypt 14 201 0.5× 104 0.9× 129 2.0× 3 0.0× 81 1.5× 24 501
H. S. Robinson Canada 10 214 0.5× 64 0.5× 31 0.5× 12 0.2× 55 1.0× 23 376
Bogdan Batko Poland 15 266 0.7× 75 0.6× 48 0.7× 6 0.1× 202 3.7× 63 528

Countries citing papers authored by J. L. Hülsemann

Since Specialization
Citations

This map shows the geographic impact of J. L. Hülsemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Hülsemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Hülsemann more than expected).

Fields of papers citing papers by J. L. Hülsemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. L. Hülsemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Hülsemann. The network helps show where J. L. Hülsemann may publish in the future.

Co-authorship network of co-authors of J. L. Hülsemann

This figure shows the co-authorship network connecting the top 25 collaborators of J. L. Hülsemann. A scholar is included among the top collaborators of J. L. Hülsemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. Hülsemann. J. L. Hülsemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boeker, Martin, Sebastian Wagner, Martin Lablans, et al.. (2017). Integrating clinical decision support systems for pharmacogenomic testing into clinical routine - a scoping review of designs of user-system interactions in recent system development. BMC Medical Informatics and Decision Making. 17(1). 81–81. 41 indexed citations
2.
Lakomek, H.‐J., et al.. (2008). Das G-DRG-System 2008. Zeitschrift für Rheumatologie. 67(3). 241–251. 3 indexed citations
3.
Lakomek, H.‐J., et al.. (2007). Klinische Behandlungspfade in der akut-stationären Rheumatologie – ein strukturiertes Prozessmanagement. Zeitschrift für Rheumatologie. 66(3). 247–254. 13 indexed citations
4.
Hülsemann, J. L., et al.. (2007). Kooperation zwischen Hausärzten und Rheumatologen in Niedersachsen: Ergebnisse einer Hausarztbefragung. 66(2). 142–151. 5 indexed citations
5.
Hülsemann, J. L., et al.. (2007). Kooperation zwischen Hausärzten und Rheumatologen in Niedersachsen. Zeitschrift für Rheumatologie. 66(2). 142–151. 5 indexed citations
6.
Hülsemann, J. L., et al.. (2006). Frühdiagnose von Arthritiden und Spondyloarthritiden im Rahmen einer Integrierten Versorgung in Niedersachsen. Zeitschrift für Rheumatologie. 65(1). 70–74. 8 indexed citations
7.
Lakomek, H.‐J., et al.. (2006). Zunehmend sachgerechte Abbildung der Rheumatologie im G-DRG-Fallpauschalensystem 2006. Zeitschrift für Rheumatologie. 65(1). 46–51. 16 indexed citations
8.
Lakomek, H.‐J., et al.. (2006). Was ändert sich für die Rheumatologie im G-DRG-System 2006?. Zeitschrift für Rheumatologie. 65(4). 333–339. 1 indexed citations
9.
Lakomek, H.‐J., et al.. (2005). Die multimodale rheumatologische Komplexbehandlung (OPS 8-983): Herausforderungen, Lösungen und Perspektiven. Zeitschrift für Rheumatologie. 64(8). 557–563. 10 indexed citations
10.
Lakomek, H.‐J., et al.. (2005). Die multimodale rheumatologische Komplexbehandlung (OPS 8-983). Zeitschrift für Rheumatologie. 64(8). 557–563. 26 indexed citations
11.
Hülsemann, J. L., Jörg Ruof, H. Zeidler, & Thomas Mittendorf. (2005). Costs in rheumatology: results and lessons learned from the ‘Hannover Costing Study’. Rheumatology International. 26(8). 704–711. 17 indexed citations
12.
Hülsemann, J. L., et al.. (2005). Direct costs related to rheumatoid arthritis: the patient perspective. Annals of the Rheumatic Diseases. 64(10). 1456–1461. 35 indexed citations
13.
Hülsemann, J. L., et al.. (2003). [Quality management of treatment of rheumatoid arthritis in a rheumatological setting].. PubMed. 97(6). 383–90. 6 indexed citations
14.
Hülsemann, J. L., et al.. (2002). Kodierleitfaden Rheumatologie Ein Leitfaden für die klinische Praxis. Zeitschrift für Rheumatologie. 61(3). 311–335. 7 indexed citations
15.
Wagner, Annette D., et al.. (2002). Sustained response to tumor necrosis factor α–blocking agents in two patients with SAPHO syndrome. Arthritis & Rheumatism. 46(7). 1965–1968. 133 indexed citations
16.
Berthelot, Jean‐Marie, Mette Klarlund, Dennis McGonagle, et al.. (2001). Lessons from an international survey of paper cases of 10 real patients from an early arthritis clinic. CRI (Club Rhumatismes et Inflammation) Group.. PubMed. 28(5). 975–81. 18 indexed citations
17.
Ruof, Jörg, J. L. Hülsemann, & Gerold Stucki. (1999). Evaluation of costs in rheumatic diseases. Current Opinion in Rheumatology. 11(2). 104–109. 22 indexed citations
18.
Hülsemann, J. L. & H. Zeidler. (1999). Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic. Annals of the Rheumatic Diseases. 58(5). 278–280. 31 indexed citations
19.
Jendro, M. C., J. L. Hülsemann, & H. Zeidler. (1997). Das Hepatitis C-Virus und rheumatische Erkrankungen (The hepatitis C-virus and rheumatic diseases). Zeitschrift für Rheumatologie. 56(5). 276–286. 4 indexed citations
20.
Zeidler, H., et al.. (1987). Undifferentiated arthritis and spondylarthropathy as a challenge for prospective follow-up. Clinical Rheumatology. 6(S2). 112–120. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamal Al Saleh Breakdown of academic impact, for papers by S. Oliver Breakdown of academic impact, for papers by Charles Lambert Breakdown of academic impact, for papers by Maria K. Söderlin Breakdown of academic impact, for papers by Jenaro Graña Gil Breakdown of academic impact, for papers by Pil Højgaard Breakdown of academic impact, for papers by N. Santana Breakdown of academic impact, for papers by Ihab Ahmed Breakdown of academic impact, for papers by H. S. Robinson Breakdown of academic impact, for papers by Bogdan Batko
Rankless by CCL
2026